Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4086835

N#Cc1ccc(-c2cnn(-c3ccnc4[nH]ccc34)c2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.48
GRM4 Q14833 1/20 0.43
JAK3 P52333 3/20 0.39
RIPK1 Q13546 1/20 0.38
JAK1 P23458 8/20 0.38
JAK2 O60674 8/20 0.37
AURKA O14965 4/20 0.36
AURKB Q96GD4 4/20 0.36
INCENP Q9NQS7 1/20 0.36
TPX2 Q9ULW0 1/20 0.36
TYK2 P29597 2/20 0.36
GAK O14976 1/20 0.36
STK16 O75716 1/20 0.36
PIM1 P11309 1/20 0.36
AXL P30530 1/20 0.36
NEK2 P51955 1/20 0.36
STK3 Q13188 1/20 0.36
STK11 Q15831 1/20 0.36
AAK1 Q2M2I8 1/20 0.36
BMP2K Q9NSY1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100683 0.90 PRKCI (0.58) PRKCIGRM4JAK3RIPK1JAK1
Trifluoroacetic Acid SCHEMBL4088293 0.89 GRM5 (0.47) PRKCIGRM4JAK1JAK2
Trifluoroacetic Acid SCHEMBL4093375 0.89 PRKCI (0.45) PRKCIGRM4JAK3JAK1JAK2
Trifluoroacetic Acid SCHEMBL4094741 0.88 PRKCI (0.44) PRKCIGRM4JAK3JAK1JAK2
Trifluoroacetic Acid SCHEMBL4082707 0.88 PRKCI (0.52) PRKCIGRM4RIPK1JAK1JAK2
Trifluoroacetic Acid SCHEMBL4082067 0.88 PRKCI (0.54) PRKCIGRM4JAK3JAK1JAK2
Trifluoroacetic Acid SCHEMBL4088934 0.88 PRKCI (0.46) PRKCIGRM4JAK3JAK1JAK2
Trifluoroacetic Acid SCHEMBL4095594 0.87 PRKCI (0.51) PRKCIGRM4JAK1JAK2AURKA
Trifluoroacetic Acid SCHEMBL4099614 0.85 PRKCI (0.48) PRKCIGRM4AURKAAURKBINCENP
Trifluoroacetic Acid SCHEMBL4092334 0.84 GRM4 (0.50) PRKCIGRM4JAK3JAK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130137681-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS INCYTE CORPORATION (US) 2013-05-30 US disclosed
US-8415362-B2 Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE CORPORATION (US) 2013-04-09 US disclosed
US-20090181959-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS INCYTE CORPORATION (US) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137681-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS JAK3, JAK1, JAK2 PRKCI 304/4885GRM4 2958/4885JAK3 1/4885
US-20090181959-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS JAK3, JAK1, JAK2 PRKCI 304/4885GRM4 2958/4885JAK3 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.